It is thought that immune mechanisms play an important role in the pathogenesis of myasthenia gravis.'-3 A humoral autoimmune response to acetylcholine receptor impairs neuromuscular transmission and causes clinical symptoms.4 5 Cellmediated immunity seems also to be involved in the pathogenesis of the disease, as suggested by the activation of lymphocytes from myasthenia gravis patients when incubated with acetylcholine receptor, 6 and by an excessive autoreactivity in mixed lymphocyte-thymocyte cultures in some patients.7 8 The role of these two immunological subsets in the pathogenesis of myasthenia gravis is still undefined. Evaluation of T-and B-cell subpopulations resulted in contradictory evidence.9-'1 We present the results of a study concerning lymphocyte subpopulations in myasthenia gravis patients, with particular reference to the immunofluorescence study of surface membrane immunoglobulins (SM Ig).
Patients and methods
Patients Sixteen consecutively hospitalised myasthenic patients were studied. None 
